Attention Mayo and University of Minnesota Researchers

Download the Request for Application (pdf format)

Minnesota tries to keep a med tech edge

BioBusiness Alliance leader Dale Wahlstrom and others discuss Minnesota's future in biosciences on Minnesota Public Radio. Listen to the hour-long program here.

Bioscience Conference

In February, the Minnesota Partnership hosted a conference on Minnesota's future in the biosciences industry. At the conference, the latest research that clearly shows that the door is still open for Minnesota to advance in this emerging field.

See the presentation

The research, conducted by an economic impact research firm that has tracked bioscience development potential for companies, industries, states and countries around the world offered insight into Minnesota's position in the biosciences - our strengths, challenges and opportunities. A panel of Minnesotans operating bio-businesses in the state demonstrated the economic and job-creation benefits the state's already receiving from the industry. Participants also received an update on the work of the Mayo Clinic-University of Minnesota bioscience partnership, which in just three years has become a nationally recognized model of collaboration for advancing medical research.

See the Partnership Update Presentation

Latest News

Minnesota Partnership Advances Potential MS Therapy Clinical-stage manufacturing progressing at Biovest in Minneapolis

A production laboratory founded by the Minnesota Partnership has transferred its first potential therapy — a medication for multiple sclerosis — to a processing plant in Minnesota. This step will complete purification of material to fully enable translation from preclinical to clinical development.

Minnesota Partnership Attracts New Scientists to State First pair of research recruits hired

Two nationally regarded researchers are on their way to Minnesota, thanks to the Minnesota Partnership for Biotechnology and Medical Genomics. The first pair of faculty members with complementary specializations recruited by the Partnership will soon increase research strengths at the University of Minnesota and Mayo Clinic.

Minnesota Partnership Announces New Project Awards Heart, mesothelioma, epilepsy among research targets

The Minnesota Partnership for Biotechnology and Medical Genomics is awarding nearly $6 million in state-funded research support to seven research teams. This new round of scientific exploration will provide initial support for research on heart disease, mesothelioma, infection prevention and epilepsy. Other projects include nanotech medical sensors and human-safe pesticides designed for Minnesota.